![](bg6.png)
publish ‘more of the same’. If the former, the
brightness of the spot may be functional and the
emphasis should be maintained; if the latter, it may
be dysfunctional and emphasis should be changed. A
‘light’ spot may indicate its lack of importance or
that it is an emergent focus. Last, a ‘blank’ spot may
be unimportant or important but overlooked. If
unimportant it may need to be so; if important the
emphasis needs to be changed.
A ‘bright’ spot in science and a corresponding
‘blank/blind’ spot in practice may indicate the need
for translation or the practical irrelevance of the
research. By the same token, a ‘blank/blind’ spot in
science and a corresponding ‘bright’ spot in practice
may indicate misplaced practice or a practice which
needs to be researched.
Thus through an analysis of the antecedents and
consequences of the gaps within the domains of
science, practice, and policy and between them using
the ontology one can construct a better roadmap for
use of HIS. While we have focused the discussion in
this paper broadly on the use of HIS, the method can
be used to develop better roadmaps in specific areas
of healthcare where information systems play a
critical role – for example, long-term breast cancer
care, care for chronic illnesses, and tele-healthcare.
We believe a systematic, systemic, and symmetric
approach to these problems should be the standard.
REFERENCES
Blumenthal, D. 2009. Stimulating the adoption of health
information technology. New England Journal of
Medicine, 360, 1477-1479.
Callen, J. L., Westbrook, J. I., Georgiou, A. & Li, J. 2011.
Failure to Follow-Up Test Results for Ambulatory
Patients: A Systematic Review. Journal of General
Internal Medicine, 27, 1334-1348.
Centers for Medicare & Medicaid Services. Meaningful
Use (Online). Available: https://www.cms.gov/
Regulations-and-
Guidance/Legislation/EHRIncentivePrograms/Meanin
gful_Use.html.
Classen, D. C., Phansalkar, S. & Bates, D. W. 2011.
Critical drug-drug interactions for use in electronic
health records systems with computerized physician
order entry: review of leading approaches. Journal of
Patient Safety, 7, 61-65.
Crosson, J. C., Schueth, A. J., Isaacson, N. & Bell, D. S.
2012. Early adopters of electronic prescribing struggle
to make meaningful use of formulary checks and
medication history documentation. The Journal of the
American Board of Family Medicine, 25, 24-32.
Gaikwad, R., Sketris, I., Shepherd, M. & Duffy, J. 2007.
Evaluation of accuracy of drug interaction alerts
triggered by two electronic medical record systems in
primary healthcare. Health informatics journal, 13,
163-177.
Interagency Breast Cancer and Environmental Research
Coordinating Committee 2013. Breast Cancer and the
Environment: Prioritizing Prevention.
http://www.niehs.nih.gov/about/assets/docs/ibcercc_fu
ll.pdf.
Phansalkar, S., Desai, A. A., Bell, D., Yoshida, E., Doole,
J., Czochanski, M., Middleton, B. & Bates, D. W.
2012a. High-priority drug–drug interactions for use in
electronic health records. Journal of the American
Medical Informatics Association, 19, 735-743.
Phansalkar, S., van der Sijs, H., Tucker, A. D., Desai, A.
A., Bell, D. S., Teich, J. M., Middleton, B. & Bates, D.
W. 2012b. Drug–drug interactions that should be non-
interruptive in order to reduce alert fatigue in
electronic health records. Journal of the American
Medical Informatics Association.
Platt, J. R. 1964. Strong inference. Science, 146, 347-353.
Rahmner, P. B., Eiermann, B., Korkmaz, S., Gustafsson,
L. L., Gruvén, M., Maxwell, S., Eichle, H.-G. & Vég,
A. 2012. Physicians' reported needs of drug
information at point of care in Sweden. British Journal
of Clinical Pharmacology, 73, 115-125.
Ramaprasad, A. & Thirumalai, M. 2012. Managing
Population Health: An Ontological Framework
(Poster). 2012 Summit on the Science of Eliminating
Health Disparities. Washington DC, USA.
Seidling, H. M., Phansalkar, S., Seger, D. L., Paterno, M.
D., Shaykevich, S., Haefeli, W. E. & Bates, D. W.
2011. Factors influencing alert acceptance: a novel
approach for predicting the success of clinical decision
support. Journal of the American Medical Informatics
Association, 18, 479-484.
Smithburger, P. L., Buckley, M. S., Bejian, S.,
Burenheide, K. & Kane-Gill, S. L. 2011. A critical
evaluation of clinical decision support for the
detection of drug-drug interactions. Expert Opinion on
Drug Safety, 10, 871-882.
Spina, J. R., Glassman, P. A., Simon, B., Lanto, A., Lee,
M., Cunningham, F. & Good, C. B. 2011. Potential
Safety Gaps in Order Entry and Automated Drug
Alerts: A Nationwide Survey of VA Physician Self-
Reported Practices With Computerized Order Entry.
Medical Care, 49, 904-910.
Takarabe, M., Shigemizu, D., Kotera, M., Goto, S. &
Kanehisa, M. 2011. Network-Based Analysis and
Characterization of Adverse Drug–Drug Interactions.
Journal of chemical information and modeling, 51,
2977-2985.
HEALTHINF2014-InternationalConferenceonHealthInformatics
386